National Institute on Drug Abuse; Notice of Closed Meeting
Published date | 10 December 2021 |
Citation | 86 FR 70511 |
Record Number | 2021-26819 |
Section | Notices |
Court | National Institutes Of Health |
Federal Register, Volume 86 Issue 235 (Friday, December 10, 2021)
[Federal Register Volume 86, Number 235 (Friday, December 10, 2021)] [Notices] [Pages 70511-70512] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2021-26819] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning [[Page 70512]] individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory. Date: February 3, 2022. Time: 10:00 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Rebekah Feng, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Drug Abuse, NIH, 3WFN 09C49, MSC 6021, 301 North Stonestreet Avenue, Rockville, MD 20892, (301) 827-7245, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: December 7, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021-26819 Filed 12-9-21; 8:45 am] BILLING CODE 4140-01-P